NSU College of Optometry investigators awarded NIH grant to study convergence insufficiency

The National Eye Institute of the National Institutes of Health has awarded up to $556,532 to investigators at Nova Southeastern University's (NSU) College of Optometry to study the relationship between the vision condition, convergence insufficiency, and reading performance and attention.

The grant will fund the Convergence Insufficiency Treatment Trial-Attention and Reading Trial (CITT-ART), a national multi-center clinical trial that involves optometry, ophthalmology, psychiatry and education in determining how this eye-teaming problem impacts a child's attention and reading performance.

Convergence insufficiency is a common vision disorder in which the eyes turn slightly outward when a person is reading or doing work close to his or her eyes.

"Children who have convergence insufficiency sometimes suffer from poor reading performance and attention problems," said Rachel A. "Stacey" Coulter, O.D., M.S.Ed., principal investigator for NSU College of Optometry's research team. "As the first large-scale randomized clinical trial to study this problem, outcomes of this study could lead to new therapies for some children with attention deficit hyperactivity disorder and reading problems. We are very excited that the National Eye Institute has funded our grant application, and we look forward to enrolling children into the study this fall."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Global study reports significant decline in diarrheal disease mortality